{
    "root": "303a8d17-68c8-fd01-e063-6394a90a4fd8",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Sildenafil",
    "value": "20250313",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "ANHYDROUS DIBASIC CALCIUM PHOSPHATE",
            "code": "L11K75P92J"
        },
        {
            "name": "HYPROMELLOSE 2910 (15 MPA.S)",
            "code": "36SFW2JZ0W"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673"
        },
        {
            "name": "SILDENAFIL CITRATE",
            "code": "BW9B0ZE037"
        }
    ],
    "indications": "Adults\n                  \n                  \n                  Sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening\n \n  [see\n  \n   Clinical Studies (14)]\n \n  . \n  \n                     \n                          Pediatric use information is approved for Viatris Specialty LLC's, REVATIO (sildenafil) tablets. However, due to Viatris Specialty LLC's marketing exclusivity rights, this drug product is not labeled with that information\n  .",
    "contraindications": "Adults: 20 mg three times a day. ( 2.1 ) Injection (Adults): 10 mg three times a day administered as an intravenous bolus injection. ( 2.1 )",
    "warningsAndPrecautions": "Sildenafil Tablets USP, 20 mgare white colored, round shape, biconvex, film-coated  tablets, debossed with ‘T’ on one side and ‘27’ on other side. \n  \n                       Bottles of 10                              NDC 43063-982-10 \n  \n                       Bottles of 30                              NDC 43063-982-30 \n  \n                       Recommended Storage for Sildenafil Tablets USP: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].",
    "adverseReactions": "Sildenafil tablets are contraindicated in patients with:\n                  \n                  \n                     Concomitant use of organic nitrates in any form, either regularly or intermittently, because of the greater risk of hypotension\n  \n   [see\n   \n    Warnings and Precautions (5.1)]\n  \n   .\n \n  \n                     Concomitant use of riociguat, a guanylate cyclase stimulator. Phosphodiesterase-5 (PDE-5) inhibitors, including sildenafil, may potentiate the hypotensive effects of riociguat.\n                     Known hypersensitivity to sildenafil or any component of the tablet, injection, or oral suspension. Hypersensitivity, including anaphylactic reaction, anaphylactic shock and anaphylactoid reaction, has been reported in association with the use of sildenafil."
}